A phase II randomized, controlled trial of continuous hemofiltration in sepsis.
about
Clinical review: extracorporeal blood purification in severe sepsisPro/con clinical debate: is high-volume hemofiltration beneficial in the treatment of septic shock?Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survivalRenal angina: an emerging paradigm to identify children at risk for acute kidney injuryClinical review: use of renal replacement therapies in special groups of ICU patientsManagement and Novel Adjuncts of Necrotizing Soft Tissue Infections.Immunomodulatory effect of continuous venovenous hemofiltration during sepsis: preliminary dataHemodynamic goals in randomized clinical trials in patients with sepsis: a systematic review of the literature.Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a.Early High-Volume Hemofiltration versus Standard Care for Post-Cardiac Surgery Shock. The HEROICS Study.Early veno-venous haemodiafiltration for sepsis-related multiple organ failureBlood purification and mortality in sepsis: a meta-analysis of randomized trialsRenal replacement therapy review: past, present and future.Novel therapies for sepsis: antiendotoxin therapies.The Japanese guidelines for the management of sepsis.Renal replacement therapy in the intensive care unit.Clinical review: blood purification for sepsis.Sequential blood purification therapy for critical patients with hyperlipidemic severe acute pancreatitisAcute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsisEarly Fluid Resuscitation and High Volume Hemofiltration Decrease Septic Shock Progression in Swine.What is new in cytokine research related to trauma/critical care.Current status of dosing and quantification of acute renal replacement therapy. Part 1: mechanisms and consequences of therapy under-delivery.Recent clinical advances in the management of critically ill patients with acute renal failure.Pediatric sepsis: challenges and adjunctive therapies.Renal replacement therapy: to treat, or not to treat, that is the question...Norepinephrine to increase blood pressure in endotoxaemic pigs is associated with improved hepatic mitochondrial respiration.A simple mathematical model of cytokine capture using a hemoadsorption device.The implications and management of septic acute kidney injury.Clinical review: timing of renal replacement therapy.The Effects of Continuous Blood Purification for SIRS/MODS Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Early continuous veno-venous haemofiltration in the management of severe acute pancreatitis complicated with intra-abdominal hypertension: retrospective review of 10 years' experience.Approaches to the Management of Acute Kidney Injury in Children.Clinical approach to the patient with AKI and sepsis.Early Versus Late Initiation of Renal Replacement Therapy in Critically Ill Patients: Systematic Review and Meta-Analysis.Management of renal replacement therapy in ICU patients: an international survey.Very high volume hemofiltration with the Cascade system in septic shock patients.Alteco endotoxin hemoadsorption in Gram-negative septic shock patientsEstimated glomerular filtration rate correlates poorly with four-hour creatinine clearance in critically ill patients with acute kidney injury.Should we apply "early" initiation of renal replacement therapy to critically ill patients with acute kidney injury?Effects of hemoadsorption on cytokine removal and short-term survival in septic rats.
P2860
Q24794487-260207BD-3B39-40AE-B8A2-B7676F911528Q24798065-70195C38-7F96-4D0D-B03C-61EDFC84768FQ24817060-DD223AD6-5EB9-4D34-A409-EDE1A79FD2EAQ26829173-4EC03E91-910F-4111-9022-FB60513F59B6Q26853350-F5AD8693-1897-4405-932B-820A2986BB1FQ30234954-4F301531-B911-4AE3-934D-260F3296CBBCQ30663053-47FF49F5-CC82-42B7-8B77-170629D1B72EQ33288475-ADEDFD06-422B-4179-A84D-7E6F5D6720A2Q33377675-4E322706-5513-4F7E-A2D5-88112D50A7BDQ33424340-59AF8C75-4DA5-4D97-ACF2-2784CEDE4FB9Q34480760-E5C3A57C-A0C4-459E-AA71-3FE2CE853A45Q34824051-E6035D07-99C7-4F0E-8350-7EDA6619F513Q34852454-6B704E10-9ABD-47EF-BF18-458502590921Q35011910-EC1F4AD2-95FC-4ABA-95F0-77FB84095459Q35107094-8466A1AF-5F4D-4DD5-9FCC-DBEF4E7BE1C6Q35166673-71B7C692-92CD-4C15-BFD8-884B63C6B06BQ35567169-1B42ED95-C7B7-4CF3-808B-1317CE48BDC2Q35651554-413ACF73-7C8D-4C07-AFD9-67C672BE74ACQ35718355-824D53ED-0588-4D18-8F85-7E8F99F735CBQ36205712-4A272B9B-D678-4953-9E2F-564411DABD0FQ36421394-CDD1C3D0-BCCE-4053-9A23-244842A6F904Q36498426-3BA43039-884A-44BA-A9E6-DBBE8EF3124FQ36604818-3217B485-0CD7-40F6-A87D-781F76D10B00Q36728513-FC89F4B8-41E9-48AD-8A84-48F45B55C762Q36902386-D1805009-D37B-4599-9A88-5CB18BB7A035Q36955198-8E2FD197-880C-44E1-B248-5C82E45FB4B7Q37378947-0C73F135-1EF0-474F-B041-4B1BEEDED9D0Q37848649-C7B7FF68-2730-49EF-91E0-304DE1629145Q37889415-A7B40746-850A-4DAB-BAAE-36C3E126D429Q38051353-7DBF2492-A94C-48C6-920F-E5797512783BQ38071101-2F8DC1BC-69AC-4D90-8E92-9B148DC4D6AAQ38094041-F61E27F3-6F06-422C-8A61-4A2F98B8DB5AQ38386070-D9C038BE-E056-448C-ACD9-F82C8CA3D98AQ39343308-CA038B78-F0B4-40D6-8647-E61DB3211274Q39548732-E22B22F0-7015-43E4-BAF3-6E4BFD668942Q40968473-521173DC-7C3B-49F3-BD9B-FA5DB3D93CEFQ41946739-6FCC800C-254C-4A93-915D-8F5FBEE62A90Q42276788-AAF3692D-314E-430D-87D0-C05584C1C056Q42369284-AC22F2AA-5BBA-4987-9A32-DFA758B055A3Q42774476-A13AC749-F18E-46AB-9224-1BC9BCC81034
P2860
A phase II randomized, controlled trial of continuous hemofiltration in sepsis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
A phase II randomized, controlled trial of continuous hemofiltration in sepsis.
@en
A phase II randomized, controlled trial of continuous hemofiltration in sepsis.
@nl
type
label
A phase II randomized, controlled trial of continuous hemofiltration in sepsis.
@en
A phase II randomized, controlled trial of continuous hemofiltration in sepsis.
@nl
prefLabel
A phase II randomized, controlled trial of continuous hemofiltration in sepsis.
@en
A phase II randomized, controlled trial of continuous hemofiltration in sepsis.
@nl
P2093
P1476
A phase II randomized, controlled trial of continuous hemofiltration in sepsis.
@en
P2093
Didier Journois
Graeme Hart
Louise Cole
Peter Tipping
Piers Davenport
P304
P356
10.1097/00003246-200201000-00016
P407
P577
2002-01-01T00:00:00Z